Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/05/2009CA2722624A1 Tetrazole compounds for reducing uric acid
11/05/2009CA2722577A1 4-oxo-1,4-dihydroquinoline m1 receptor positive allosteric modulators
11/05/2009CA2722571A1 Pharmaceutical gallium compositions and methods
11/05/2009CA2722487A1 Imidazolidinone derivatives as 11b-hsd1 inhibitors
11/05/2009CA2722427A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009CA2722408A1 Lipid composition
11/05/2009CA2722347A1 Piperidine and pyrrolidine compounds
11/05/2009CA2722295A1 Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate
11/05/2009CA2722270A1 Steroidal compounds as melanogenesis modifiers and uses thereof
11/05/2009CA2722220A1 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
11/05/2009CA2722131A1 Imidazo-pyridine derivatives as activin-like receptor kinase (alk4 or alk5) inhibitors
11/05/2009CA2722122A1 Benzocycloheptane and benzoxepine derivatives
11/05/2009CA2722114A1 4-trimethylammonio-butyrates as cpt2 inhibitors
11/05/2009CA2722087A1 4-dimethylaminobutyric acid derivatives
11/05/2009CA2722050A1 Polymerized micelles
11/05/2009CA2721981A1 Methods and kits for the treatment of inflammatory bowel disorder conditions
11/05/2009CA2721560A1 Combination of dronedarone with at least one diuretic, and therapeutic use thereof
11/05/2009CA2720908A1 Molecules inhibiting a metabolic pathway involving the syk protein tyrosine kinase and method for identifying said molecules
11/05/2009CA2720850A1 Hcv ns3 protease inhibitors
11/05/2009CA2720846A1 Novel inhibitors of hepatitis c virus replication
11/05/2009CA2720516A1 Indoline anti-cancer agents
11/05/2009CA2720008A1 Porous crystalline hybrid solid for adsorbing and releasing gas of biological interest
11/05/2009CA2719365A1 Spiro-indole derivatives for the treatment of parasitic diseases
11/05/2009CA2716936A1 Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
11/05/2009CA2713379A1 Optimized methods for delivery of dsrna targeting the pcsk9 gene
11/04/2009EP2113569A1 Recombinant adenoviral vector and methods of use
11/04/2009EP2113518A1 Bone/cartilage formation-stimulating agent
11/04/2009EP2113509A2 Modulation of the expression of STAT-1 dependent genes
11/04/2009EP2113508A1 Novel triazole nucleoside derivatives, their preparation and their application in therapeutics
11/04/2009EP2113506A2 Salts of clopidogrel and process for preparation
11/04/2009EP2113505A1 A crystalline form III of anhydrous moxifloxacin hydrochloride and processes for the preparation thereof
11/04/2009EP2113504A1 Preparation of N-6 demethylated, 9,10-dihydrolysergic acid alkyl esters
11/04/2009EP2113503A1 New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
11/04/2009EP2113502A1 Hydrazyde type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
11/04/2009EP2113501A1 5-Methyl-1-(naphthalen-2-YL)-1H-Pyrazoles useful as sigma receptor inhibitors
11/04/2009EP2113315A2 Disposal system for transdermal dosage form
11/04/2009EP2113257A1 Polyelectrolyte with positive net charge for use as medicament and diagnostic for cancer
11/04/2009EP2113252A1 A forsythoside injection and preparation thereof
11/04/2009EP2113251A1 Use of compounds as inhibitors for helicobacter flavodoxin
11/04/2009EP2113249A1 Antimycotic patch
11/04/2009EP2113248A1 Pharmaceutical composition comprising N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2-,4-dimethyl-1H-pyrrole-3-carboxamide
11/04/2009EP2113247A2 High efficiency encapsulation of nucleic acids in lipid vesicles
11/04/2009EP2113246A1 Compositions for delivery of therapeutics into the eyes and methods for making and using the same
11/04/2009EP2113230A2 Drug-Delivery Endovascular Stent and Method for Treating Restenosis
11/04/2009EP2113030A2 Genes involved in mitochondrial biogenesis
11/04/2009EP2112995A2 23-substituted bile acids as tgr5 modulators and methods of use thereof
11/04/2009EP2112993A1 Substituted tetrahydropyrrolopyrazine compounds having affinity with the kcnq2/3 k+ channel and use thereof in medicaments
11/04/2009EP2112931A1 Methods and compositions for transermal delivery of nucleotides
11/04/2009EP2112928A1 Synthesis of novel xylosides and potential uses thereof
11/04/2009EP2112927A2 Method for treatment of overfiltering and leaking blebs with sterile talc
11/04/2009EP2112926A2 Use of estrogen receptor beta selective ligands for treating acute lung injuries
11/04/2009EP2112925A2 Solid pharmaceutical dosage formulations
11/04/2009EP2112924A1 Delta 9 - tetrahydrocannabinol processing
11/04/2009EP2112923A1 Intranasal, buccal, and sublingual administration of metanicotine analogs
11/04/2009EP2112920A1 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
11/04/2009EP2112880A2 Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment
11/04/2009EP1979345B1 Novel pyridine derivatives
11/04/2009EP1931341B1 1h-indole-pyridinecarboxamide and 1h-indole-piperidinecarboxamide derivatives and their use as tyrosine hydroxylase inducers
11/04/2009EP1928442B1 Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof
11/04/2009EP1844045B1 Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
11/04/2009EP1817296B1 Potentiators of glutamate receptors
11/04/2009EP1784388B1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
11/04/2009EP1735625B1 Screening for a modulator of atherogenic lipoprotein retention
11/04/2009EP1723952B1 Antiwrinkling preparation
11/04/2009EP1720868B1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
11/04/2009EP1704147B1 PYRROLO[2,3-b] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION COMPRISING THEM
11/04/2009EP1651642B1 Pna monomer and precursor
11/04/2009EP1641465B1 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
11/04/2009EP1624874B1 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/04/2009EP1617806B1 Selective spirocyclic glucocorticoid receptor modulators
11/04/2009EP1615613B1 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
11/04/2009EP1553092B1 Aralkyl formyl-alkyl piperazine derivatives and their uses as cerebral nerve protective agent
11/04/2009EP1533304B1 Amide derivative
11/04/2009EP1532130B1 Process for the production of an immunosuppressant
11/04/2009EP1499311B1 Substituted benzazoles and use thereof as raf kinase inhibitors
11/04/2009EP1481077B1 Mitotic kinesin inhibitors
11/04/2009EP1480736B1 Microcapsules having high carotenoid content
11/04/2009EP1467743B1 Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application
11/04/2009EP1455773B1 2-aryl-propionic acids and pharmaceutical compositions containing them
11/04/2009EP1446387B1 Substituted aryl 1,4-pyrazine derivatives
11/04/2009EP1432700B1 Spiro-hydantoin compounds useful as anti-inflammatory agents
11/04/2009EP1425011B1 Enhancement of learning and memory and treatment of amnesia
11/04/2009EP1420645B1 Multivesicular emulsion topical delivery systems
11/04/2009EP1372638B1 Cannabinoids for the treatment of breathing disorders during sleep
11/04/2009EP1366040B1 Amorphous form of cell cycle inhibitor
11/04/2009EP1339684B1 Mch antagonists and their use in the treatment of obesity
11/04/2009EP1311488B1 Substituted imidazoles as tafia inhibitors
11/04/2009EP1303488B1 Piperidine compounds for use as ccr-3 inhibitors
11/04/2009EP1272049B1 Method for the fractionation of oil and polar lipid-containing native raw materials using alcohol and centrifugation
11/04/2009EP1204430B1 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/04/2009EP1140039B1 Transparent transdermal nicotine delivery devices
11/04/2009EP1011695B2 Use of neurotoxin therapy for treatment of prostate disorders
11/04/2009EP1004299B1 Vaccine precursors, vaccines for treating tumors
11/04/2009EP0879236B1 Derivatives of camptothecin for use in treating cancer
11/04/2009CN101573363A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
11/04/2009CN101573360A Heteroaryl compounds, compositions thereof, and methods of treatment therewith
11/04/2009CN101573357A 吲哚化合物 Indole compound
11/04/2009CN101573356A Modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
11/04/2009CN101573354A Substituted isoquinolines and their use as Rho-kinase inhibitors
11/04/2009CN101573353A Substituted isoquinoline and isoquinolinone derivatives
1 ... 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 ... 7860